A novel AbetaPP mutation exclusively associated with cerebral amyloid angiopathy.

Article Details

Citation

Obici L, Demarchi A, de Rosa G, Bellotti V, Marciano S, Donadei S, Arbustini E, Palladini G, Diegoli M, Genovese E, Ferrari G, Coverlizza S, Merlini G

A novel AbetaPP mutation exclusively associated with cerebral amyloid angiopathy.

Ann Neurol. 2005 Oct;58(4):639-44.

PubMed ID
16178030 [ View in PubMed
]
Abstract

Mutations in AbetaPP cause deposition of Abeta amyloid fibrils in brain parenchyma and cerebral vessels, resulting in Alzheimer's disease (AD) and/or cerebral amyloid angiopathy (CAA). We report a novel mutation (L705V) within the Abeta sequence of AbetaPP in a family with autosomal dominant, recurrent intracerebral hemorrhages. Pathological examination disclosed severe CAA, without parenchymal amyloid plaques or neurofibrillary tangles. This variant highlights the vascular tropism of mutated Abeta, resulting in CAA instead of the pathological hallmarks of AD.

DrugBank Data that Cites this Article

Polypeptides
NameUniProt ID
Amyloid beta A4 proteinP05067Details